Previous 10 | Next 10 |
HERTFORDSHIRE, England and PITTSBURGH and SYDNEY , July 8, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) and medical device manufacturer Atomo Diagnostics today announced that the Mylan HIV Self Test , a handheld in vitro HIV...
AbbVie ( ABBV ) had entered into a deal to acquire Allergan ( AGN ) for $63 billion, which would be $188 a share in cash and stock. This was a huge premium of 45% over the closing price of $129.57 on Monday, June 25, 2019. AbbVie's stock tanked on this news, closing lower by 16%. In my...
Acorda Therapeutics ( ACOR ) has had a difficult year with the genericization of their AMPYRA asset coming from a court decision in September 2018. The company has lost over half of its equity value YTD and investors have been continually selling shares even amidst a strong bull market. Howe...
MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), a leading specialty pharmaceutical company with a strong North American commercial platform, announces that Adele M. Gulfo has joine...
Karuna Therapeutics ( KRTX ) has filed to raise gross proceeds of up to $70 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing new therapeutics for debilitating neuropsychiatric conditions with high unmet medical needs. KRTX has a late 2019 pote...
In the past couple of weeks, shares of Teva Pharmaceuticals ( TEVA ) and Mylan ( MYL ) have been hit hard due to headlines about price-fixing and opioid claims. The drop in these stocks appears to be way overdone based on the fact that these legal issues are nothing new. The price-fixing lawsu...
The Stock Exchange is all about trading. Each week, we do the following: Discuss an important issue for traders; Highlight several technical trading methods, including current ideas; Feature advice from top traders and writers; and Provide a few (minority) reactions from fundamenta...
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH , June 14, 2019 /PRNewswire/ -- Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced the expansion of t...
By Vinay Thapar Healthcare stocks served as powerful painkillers during last year's market declines. Yet the sector offers much more than just downside protection for investors who focus on business potential and resist the urge to predict scientific breakthroughs. While the MSCI World I...
Teva Pharmaceutical Industries ( TEVA -4.2% ) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the continued erosion of Copaxone sales (down 56% in Q1) and its potential exposure from opioid ...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...